Search

Author/Creator Ilan, Y.

3. Oral administration of non‐absorbable delayed release 6‐mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. (August 2015)

Authors:
Israeli, E.; Goldin, E.; Fishman, S.; Konikoff, F.; Lavy, A.; Chowers, Y.; Melzer, E.; Lahat, A.; Mahamid, M.; Shirin, H.; Nussinson, E.; Segol, O.; Ya'acov, A. Ben; Shabbat, Y.; Ilan, Y.
Journal:
Clinical and experimental immunology
Issue:
Volume 181:Number 2(2015:Aug.)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Oral administration of non‐absorbable delayed release 6‐mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. (August 2015)

Authors:
Israeli, E.; Goldin, E.; Fishman, S.; Konikoff, F.; Lavy, A.; Chowers, Y.; Melzer, E.; Lahat, A.; Mahamid, M.; Shirin, H.; Nussinson, E.; Segol, O.; Ya'acov, A. Ben; Shabbat, Y.; Ilan, Y.
Journal:
Clinical and experimental immunology
Issue:
Volume 181:Number 2(2015:Aug.)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial. Issue 8 (21st November 2014)

Authors:
Halota, W.; Ferenci, P.; Kozielewicz, D.; Dybowska, D.; Lisovoder, N.; Samira, S.; Shalit, I.; Ellis, R.; Ilan, Y.
Journal:
Journal of viral hepatitis
Issue:
Volume 22:Issue 8(2015)
Page Start:
651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗